| The concise guide to pharmacology 2019/20: Enzymes SPH Alexander, D Fabbro, E Kelly, A Mathie, JA Peters, EL Veale, ... British Journal of Pharmacology 176, S297-S396, 2019 | 532 | 2019 |
| Polydopamine-based simple and versatile surface modification of polymeric nano drug carriers J Park, TF Brust, HJ Lee, SC Lee, VJ Watts, Y Yeo ACS nano 8 (4), 3347-3356, 2014 | 410 | 2014 |
| Morphine-induced alterations of immune status: dose dependency, compartment specificity and antagonism by naltrexone. DT Lysle, ME Coussons, VJ Watts, EH Bennett, LA Dykstra Journal of Pharmacology and Experimental Therapeutics 265 (3), 1071-1078, 1993 | 228 | 1993 |
| Serotonin 5-hydroxytryptamine2A receptor-coupled phospholipase C and phospholipase A2 signaling pathways have different receptor reserves DM Kurrasch-Orbaugh, VJ Watts, EL Barker, DE Nichols Journal of Pharmacology and Experimental Therapeutics 304 (1), 229-237, 2003 | 210 | 2003 |
| International union of basic and clinical pharmacology. CI. Structures and small molecule modulators of mammalian adenylyl cyclases CW Dessauer, VJ Watts, RS Ostrom, M Conti, S Dove, R Seifert Pharmacological reviews 69 (2), 93-139, 2017 | 205 | 2017 |
| WAY-100635 is a potent dopamine D4 receptor agonist BR Chemel, BL Roth, B Armbruster, VJ Watts, DE Nichols Psychopharmacology 188, 244-251, 2006 | 178 | 2006 |
| D2 dopamine receptors modulate Gα-subunit coupling of the CB1 cannabinoid receptor A Jarrahian, VJ Watts, EL Barker Journal of Pharmacology and Experimental Therapeutics 308 (3), 880-886, 2004 | 177 | 2004 |
| Effect of ring fluorination on the pharmacology of hallucinogenic tryptamines JB Blair, D Kurrasch-Orbaugh, D Marona-Lewicka, MG Cumbay, VJ Watts, ... Journal of medicinal chemistry 43 (24), 4701-4710, 2000 | 175 | 2000 |
| Sensitization of adenylate cyclase by Gαi/o-coupled receptors VJ Watts, KA Neve Pharmacology & therapeutics 106 (3), 405-421, 2005 | 170 | 2005 |
| Molecular mechanisms for heterologous sensitization of adenylate cyclase VJ Watts Journal of Pharmacology and Experimental Therapeutics 302 (1), 1-7, 2002 | 155 | 2002 |
| A complex signaling cascade links the serotonin2A receptor to phospholipase A2 activation: the involvement of MAP kinases DM Kurrasch‐Orbaugh, JC Parrish, VJ Watts, DE Nichols Journal of neurochemistry 86 (4), 980-991, 2003 | 147 | 2003 |
| Sensitization of endogenous and recombinant adenylate cyclase by activation of D2 dopamine receptors. VJ Watts, KA Neve Molecular Pharmacology 50 (4), 966-976, 1996 | 133 | 1996 |
| Ligand-dependent oligomerization of dopamine D2 and adenosine A2A receptors in living neuronal cells PA Vidi, BR Chemel, CD Hu, VJ Watts Molecular pharmacology 74 (3), 544-551, 2008 | 125 | 2008 |
| Homologous desensitization of the D1A dopamine receptor: efficacy in causing desensitization dissociates from both receptor occupancy and functional potency MM Lewis, VJ Watts, CP Lawler, DE Nichols, RB Mailman Journal of Pharmacology and Experimental Therapeutics 286 (1), 345-353, 1998 | 119 | 1998 |
| LSD and structural analogs: pharmacological evaluation at D1 dopamine receptors VJ Watts, RB Mailman, CP Lawler, KA Neve, DE Nichols Psychopharmacology 118, 401-409, 1995 | 116 | 1995 |
| Regulatory properties of adenylate cyclases type 5 and 6: A progress report MA Beazely, VJ Watts European journal of pharmacology 535 (1-3), 1-12, 2006 | 112 | 2006 |
| Structure of Gαi1 bound to a GDP-selective peptide provides insight into guanine nucleotide exchange CA Johnston, FS Willard, MR Jezyk, Z Fredericks, ET Bodor, MB Jones, ... Structure 13 (7), 1069-1080, 2005 | 105 | 2005 |
| A “Genome-to-Lead” Approach for Insecticide Discovery: Pharmacological Characterization and Screening of Aedes aegypti D1-like Dopamine Receptors JM Meyer, KFK Ejendal, LV Avramova, EE Garland-Kuntz, ... PLoS neglected tropical diseases 6 (1), e1478, 2012 | 103 | 2012 |
| Adenosine A2A receptors assemble into higher-order oligomers at the plasma membrane PA Vidi, J Chen, JMK Irudayaraj, VJ Watts Febs Letters 582 (29), 3985-3990, 2008 | 101 | 2008 |
| 8,9-Dihydroxy-2,3,7,11b-tetrahydro-1H-naph[1,2,3-de]isoquinoline: A Potent Full Dopamine D1 Agonist Containing a Rigid β-Phenyldopamine Pharmacophore D Ghosh, SE Snyder, VJ Watts, RB Mailman, DE Nichols Journal of medicinal chemistry 39 (2), 549-555, 1996 | 100 | 1996 |
